• Our researchers are experts in the life sciences, clinical advancements, drug development and alternative therapies for the prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

  • Our bedside to bench translational approach enables our physician scientists to take what they learn from clinical interaction with patients directly to the laboratory, in order to improve our knowledge of these diseases and to improve treatments.

  • The support and involvement of our community partners such as local clinics, schools and Arizona citizens is instrumental in our pursuit of a world that breathes easy.

Message from the Director

Welcome to the Asthma & Airway Disease Research Center, an internationally renowned organization of physicians, scientists, and scholars seeking to understand and eradicate airway disease.

I am convinced that in the next few decades we will find cures for the most common respiratory diseases affecting both children and adults. I also believe that the Asthma & Airway Disease Research Center will continue playing a central role in this quest. On behalf of the Center's physicians, scientists, nurses, and staff who are so dedicated to improving people's lives, I thank you for your interest in our work. Your support is vital to our success.

 

Fernando D. Martinez, MD
Regents' Professor
Director, Asthma & Airway Disease Research Center

About the Center

Asthma & Airway Disease Research Center is an interdisciplinary Center of Excellence at the University Of Arizona dedicated to research, clinical care, medical education, and community service in the areas of adult and pediatric pulmonary medicine. 

Learn More

Advancing the UAHS Pillars of Excellence

Health Wellbeing and Quality of All 

The Asthma & Airway Disease Research Center is one of the elite ALA Airway Clinical Research Centers

Innovation Powerhouse

We are developing 2 brand new molecule families for the treatment of asthma and investigating new therapeutic applications of existing medicines

Aging for Life

The Center is analyzing the connections between genetics and early life incidence, and their long-term effects on lung function throughout life

Unlock Human Resilience

A2DRC scientists are performing important work with CC16, a protein produced in the airway with protective characteristics for resilience against excessive inflammation, environmental exposures, and disease

"Future Proof" our Graduates 

Center affiliates train scores of young scientists and clinicians to prepare them for the new challenges in our changing environment

Impact

Attacking Asthma: 50 Years of Life-changing Discovery

The Asthma & Airway Disease Research Center has revolutionized our scientific understanding of asthma and other respiratory diseases. Nearly 340 million people globally and 25 million Americans – 7.7% of adults and 8.4% of children – suffer from asthma. And while there’s no cure, five decades of leading-edge research at the University of Arizona Health Sciences has helped advance scientific understanding of this respiratory illness and the therapies developed to address it.
U.S.-Mexico Asthma Study Examines Hygiene Hypothesis Amid Pandemic

Researchers are taking a three-pronged approach to analyze asthma in children in Nogales, Sonora, Mexico, and Tucson, Arizona – even before they’re born. A cross-border investigation of children’s susceptibility to asthma and other childhood illnesses in the United States and Mexico is the focus of a new study led by researchers in the Asthma and Airway Disease Research Center at the University of Arizona Health Sciences.


Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure

The study objective was to examine the effect of COVID-19 on treatment adherence and self-reported sleep duration among patients with Obstructive Sleep Apnea (OSA) treated with positive airway pressure (PAP) therapy.